Emerging GPCR targets for AUD: Insights from preclinical studies

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• G protein-coupled receptors (GPCRs) are crucial for cellular communication in the central nervous system.
• GPCRs are targeted by many existing medications and are key targets for treating brain disorders.
• Alcohol use disorder (AUD) is a significant public health issue with ongoing needs for effective treatments.

Purpose of the Study:

• To review recent literature (past 5 years) on GPCRs as therapeutic targets for reducing excessive alcohol consumption.
• To identify and summarize preclinical evidence for compounds modulating GPCRs for potential AUD treatment.
• To highlight GPCR targets with promising pharmacological profiles for future clinical investigation.

Main Methods:

• Systematic literature review focusing on preclinical studies published within the last five years.
• Analysis of research investigating G protein-coupled receptors (GPCRs) involved in alcohol intake behaviors.
• Evaluation of pharmacological profiles of compounds targeting identified GPCRs for potential efficacy in alcohol use disorder (AUD).

Main Results:

• Several GPCRs have been identified as potential targets for mitigating excessive alcohol intake.
• Preclinical studies demonstrate that modulating specific GPCRs can reduce alcohol consumption in animal models.
• Compounds targeting these GPCRs exhibit promising pharmacological properties warranting further investigation.

Conclusions:

• GPCRs represent a viable and attractive target class for developing novel therapeutics for alcohol use disorder (AUD).
• Continued preclinical research into GPCR-targeting compounds is essential for advancing AUD treatment options.
• Translating promising preclinical findings into clinical applications holds potential for managing excessive alcohol intake behaviors.